News

Tate & Lyle plc is a FTSE 250 listed global provider of speciality food and beverage ingredient solutions. With more than 165 years of innovation, the Company specialises in sweetening, mouthfeel and fortification solutions, helping food and beverage manufacturers develop healthier products without compromising on taste, texture or functionality. Tate & Lyle operates across Europe, the Americas and Asia-Pacific, serving many of the world’s leading food and beverage brands.

Ingredion Incorporated is a NYSE-listed global ingredients solutions company, supplying starches, sweeteners, texturisers, plant-based proteins and other speciality ingredients to customers in more than 120 countries. Headquartered in Westchester, Illinois, Ingredion serves the food, beverage and industrial sectors, with a strategic focus on helping customers meet growing consumer demand for healthier, more sustainable and innovative products.

The proposed combination will create a leading global speciality ingredients business with enhanced capabilities across sugar reduction, texture, fortification and formulation solutions. By bringing together complementary product portfolios, technical expertise and global manufacturing networks, the combined group is expected to be better positioned to support customers as demand continues to grow for healthier, functional and value-added food and beverage products.

On 8 June 2026, the boards of Ingredion Incorporated and Tate & Lyle plc announced that they had reached agreement on the terms of a recommended all-cash acquisition under which Ingredion will acquire the entire issued, and to be issued, ordinary share capital of Tate & Lyle.

Publication of Scheme Document

The Perivan shareholder communications team was delighted to work with Linklaters, who acted as Legal Adviser to Tate & Lyle on the production of the Scheme and associated documents which included the provision of the Engage data room platform, which was utilised for the secure proof distribution, and were successfully published and posted to qualifying shareholders on 3 July 2026.

For further information, click here.

Perivan specialise in producing and publishing financial documents relating to shareholder and investor communications for quoted companies and are a market leader for the production of documentation relating to Mergers & Acquisitions.